Skip to main content
main-content

2021 Genitourinary Cancers Symposium

VIRTUAL MEETING COVERAGE

Highlights

More expert video interviews

25-02-2021 | ASCO GU 2021 | Conference coverage | Video

Clinical insights into renal cell carcinoma trials

Nazli Dizman shares her highlights of the renal cell carcinoma presentations at the 2021 Genitourinary Cancers Symposium prostate cancer track, including the SWOG 1500 and CLEAR trials.

25-02-2021 | ASCO GU 2021 | Conference coverage | Video

Cabozantinib benefit for metastatic papillary RCC demonstrated

Sumanta Pal provides an overview of the phase 2 SWOG 1500 study pitting the MET inhibitors cabozantinib, crizotinib, and savolitinib against sunitinib for the treatment of metastatic papillary renal cell carcinoma.

19-02-2021 | ASCO GU 2021 | Conference coverage | Video

TIVO-3 results point to tivozanib activity after RCC progression on axitinib

Brian Rini describes an analysis of the TIVO-3 advanced renal cell carcinoma trial suggesting that tivozanib offers better outcomes than sorafenib even in patients who have previously received axitinib.

18-02-2021 | ASCO GU 2021 | Conference coverage | Video

Clinical insights into prostate cancer trial data

11-02-2021 | ASCO GU 2021 | Conference coverage | Video

Updated TheraP data further support LuPSMA for mCRPC

Expert video discussion

20-01-2021 | Urothelial cancer | Video

Key results on urothelial carcinoma presented at ASCO GU 2021

Fredrik Liedberg and Thomas Powles discuss their thoughts on the game-changing results on metastatic urothelial carcinoma presented at ASCO GU (15:35).

This activity is supported by an educational grant from Pfizer and Merck Healthcare KGaA, Darmstadt, Germany.

17-02-2021 | ASCO GU 2021 | Conference coverage | Video

Metastatic urothelial cancer: clinical insights into trial data

Shilpa Gupta and Petros Grivas share their thoughts on the key practicing-changing trials in metastatic urothelial cancer, including EV-301, EV-201, TITAN-TCC, and TROPiCS-04 (16:47).

17-02-2021 | ASCO GU 2021 | Conference coverage | Video

Nonmetastatic urothelial cancer: clinical insights into trial data

Petros Grivas and Shilpa Gupta discuss the key abstracts in the nonmetastatic urothelial cancer setting, sharing their thoughts on how the data inform clinical practice (10:39).

19-01-2021 | Urothelial cancer | Video

Available treatment options and emerging clinical trial data for mUC

Enrique Grande and Matthew Galsky discuss treatment options for patients with mUC and explain how new data may affect clinical practice in the future (16:15).

This activity is supported by an educational grant from Pfizer and Merck Healthcare KGaA, Darmstadt, Germany.

More research news


Medicine Matters conference coverage is brought to you in partnership with medwireNews



Image Credits